What is the enterprise value (EV) for Harvard Bioscience, Inc. (HBIO)?

The enterprise value (EV) for HBIO stock is $67.66M.

Harvard Bioscience (HBIO) Enterprise Value: History & Chart

Compare

Harvard Bioscience, Inc.(HBIO)

Medical - Instruments & Supplies · Holliston, MA

$8.62+0.12 (+1.41%)

Delayed quote: Oct 6, 2026, 12:34 PM EDT

Compare

About Harvard Bioscience, Inc.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Holliston, MA

328 employees

www.harvardbioscience.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: John D. Duke

View full financials

NAME	MARKET CAP	ENTERPRISE VALUE (EV)
Harvard Bioscience, Inc. (HBIO)	$38.88M	$67.66M
Nephros, Inc. (NEPH)vs ›	$39.96M	$36.14M
Incannex Healthcare Limited (IXHL)vs ›	$38.05M	N/A
Metagenomi, Inc. Common Stock (MGX)vs ›	$40.28M	$38.97M
Filana Therapeutics, Inc. (FLNA)vs ›	$40.46M	N/A
Edesa Biotech, Inc. (EDSA)vs ›	$37.33M	$27.00M
QT Imaging Holdings, Inc. (QTI)vs ›	$36.76M	$30.12M
Elicio Therapeutics, Inc. (ELTX)vs ›	$36.61M	$27.28M
DocGo Inc. (DCGO)vs ›	$35.88M	$36.55M
BioStem Technologies, Inc. (BSEM)vs ›	$42.29M	$36.55M

NAME

MARKET CAP

ENTERPRISE VALUE (EV)

Harvard Bioscience, Inc. (HBIO)

$38.88M

$67.66M

Nephros, Inc. (NEPH)vs ›

$39.96M

$36.14M

Incannex Healthcare Limited (IXHL)vs ›

$38.05M

N/A